Journal of Clinical Oncology
Research Hotspot & Journal Scope - urothelial
NKTR-214 + nivolumab in first-line advanced/metastatic urothelial carcinoma (mUC): Updated results from PIVOT-02.
Arlene Odelia Siefker-Radtke · Mayer Fishman · Arjun Vasant Balar · Giovanni Grignani · Adi Diab · Jianjun Gao · Mary Tagliaferri · Alison L. Hannah · Erin E. Karski · Jonathan Zalevsky · Ute Hoch · Ahsan Naqi Rizwan · Mehmet Asim Bilen ·
MedicinePlasmacytoid variant urothelial carcinoma: Clinicopathologic outcomes and experience with neoadjuvant chemotherapy.
Kyle Ericson · Lewis Thomas · Byron H. Lee ·
MedicineEV-103: Enfortumab vedotin plus pembrolizumab and/or chemotherapy for locally advanced or metastatic urothelial cancer.
Christopher J. Hoimes · Jonathan E. Rosenberg · Daniel P. Petrylak · Anne-Sophie Carret · Amal Melhem-Bertrandt · Thomas W. Flaig ·
MedicineAvelumab treatment for metastatic urothelial carcinoma in the phase Ib JAVELIN Solid Tumor Study: Updated safety and efficacy analysis with ≥ two years of follow-up.
Andrea B. Apolo · John Allan Ellerton · Jeffrey R. Infante · Manish Agrawal · Michael S. Gordon · Raid Aljumaily · Carolyn D. Britten · Luc Dirix · Keun-Wook Lee · Matthew H. Taylor · Patrick Schöffski · Ding Wang · Alain Ravaud · Junyuan Xiong · Galit Rosen · James L. Gulley · Manish R. Patel ·
MedicineEconomic burden of select adverse events (AEs) in patients (Pts) with advanced urothelial cancer (aUC) treated with first-line (1L) systemic therapy.
Petros Grivas · François Laliberté · Yunes Doleh · Cristi O’Connor · Mei Sheng Duh · Rahul Shenolikar ·
MedicineUrine cytology is non-invasive, is a low-cost method, and has a high specificity but low sensitivity for low-grade urothelial tumors.
PURPOSE This study sought to identify factors associated with survival of pT1 urothelial carcinoma of bladder (UCB) after radical cystectomy (RC).
Materials: Data from patients who underwent FDG PET/CT for suspicion of recurrent urothelial carcinoma (UC) between 2007 and 2015 were retrospectively collected in a multicenter study.
miR-29b expression correlated with low RARβ expression in renal clear cell carcinomas and bladder urothelial carcinomas, tumors associated with TSC gene mutations.
Third, in human normal urothelial SVHUC cells with exposure to a chemical carcinogen 3-methylcholanthrene (MCA), we assessed the effects of ATF2 knockdown on neoplastic transformation.
Journal of Clinical Oncology
Research Hotspot
Journal of Clinical Oncology
Journal Scope
